TRCT
XPER icon

Tower Research Capital (TRC)’s Xperi XPER Stock Holding History

Tower Research Capital (TRC)’s Portfolio XPER Stock Details XPER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1K Buy
2,870
+1,609
+128% +$9.31K ﹤0.01% 3636
2025
Q4 		$7.39K Sell
1,261
-255
-17% -$1.6K ﹤0.01% 4016
2025
Q3 		$9.82K Sell
1,516
-3,507
-70% -$23.1K ﹤0.01% 4013
2025
Q2 		$39.7K Buy
5,023
+3,899
+347% +$29.4K ﹤0.01% 3169
2025
Q1 		$8.68K Sell
1,124
-263
-19% -$2.3K ﹤0.01% 3864
2024
Q4 		$14.2K Sell
1,387
-9,744
-88% -$91K ﹤0.01% 3470
2024
Q3 		$103K Buy
11,131
+492
+5% +$4.04K ﹤0.01% 2214
2024
Q2 		$87.3K Buy
10,639
+5,602
+111% +$53K ﹤0.01% 2671
2024
Q1 		$60.7K Sell
5,037
-13,822
-73% -$152K ﹤0.01% 2146
2023
Q4 		$208K Buy
18,859
+17,336
+1,138% +$167K ﹤0.01% 2074
2023
Q3 		$15K Buy
1,523
+312
+26% +$3.69K ﹤0.01% 3640
2023
Q2 		$15.9K Sell
1,211
-162
-12% -$1.76K ﹤0.01% 3597
2023
Q1 		$15K Sell
1,373
-987
-42% -$10.3K ﹤0.01% 3830
2022
Q4 		$20K Buy
+2,360
New +$27K ﹤0.01% 3149

Other funds holding XPER

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
I
Immersion Aventura, Florida $145M AUM 17.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tower Research Capital (TRC)'s XPER Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Xperi (XPER) stake by 128% in Q1 2026, buying an estimated $9.31K and bringing the position to 2,870 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

Tower Research Capital (TRC) first reported a position in XPER in Q4 2022 and has held it in 14 quarters since. The position peaked at $208K in Q4 2023. 141 funds tracked by Wall St. Rank hold XPER as of Q1 2026.

  • Tower Research Capital (TRC) held 2,870 shares of Xperi worth $16.1K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,609 Xperi shares in Q1 2026, an estimated $9.31K.
  • Xperi made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3636 holding.
  • Tower Research Capital (TRC) first reported a position in Xperi in Q4 2022 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s Xperi position peaked at $208K in Q4 2023.
  • 141 funds tracked by Wall St. Rank held Xperi as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.